The use of siRNA (short interfering RNA) encapsulated liposomes to inhibit PAR-1 in tumor cells was associated with a reduced expression of angiogenic and metastatic genes (such as VEGF, Interleukin (IL)-8, and matrix metalloproteinase-2 (MMP-2)) and blood vessel density. This evidence concerns the gene MMP2 and neoplasm.